Popular Articles
Revitol Cellulite Cream

Evaluating The ADHD Medication VYVANSE CII Demonstrated No Change In Pharmacokinetic Profile Of VYVANSE When Coadministered With Prilosec OTC 40 Mg
Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, announced results of a study showing that coadministration of the ADHD medication VYVANSE® (lisdexamfetamine dimesylate) CII with the proton pump inhibitor (PPI) Prilosec OTC® 40 mg (20 mg X 2), did not alter the median time it took for maximum plasma concentration of d-amphetamine to be reached in the subjects evaluated. In the same study, coadministration of Prilosec OTC with ADDERALL XR resulted in a nearly 45 percent reduction in the median time to reach maximum plasma concentrations of amphetamine, the active medication. Other pharmacokinetic parameters (maximum plasma concentration and area under curve) of active medication were not altered for either VYVANSE or ADDERALL XR when coadministered with Prilosec OTC. This study, which is the first to evaluate the pharmacokinetics of VYVANSE and ADDERALL XR taken alone and with Prilosec OTC 40 mg, was recently presented at the International Congress on Clinical Pharmacy, co-sponsored by the American College of Clinical Pharmacy (ACCP), in Orlando, FL. Don't forget to buy zoloft online no prescription.

Long Term Care Insurance Receives Attention
Congress is turning its" attention to long-term care insurance producing information about how such insurance may help consumers make informed decisions for their long-term care needs.

generic viagra online


News of the day
Depomed Completes Enrollment Of Phase 3 Clinical Program Of DM-1796 In Post-Herpetic Neuralgia
Depomed, Inc. (NASDAQ:DEPO) announced that it has completed enrollment of the Phase 3 clinical trial of DM-1796 for the treatment of post-herpetic neuralgia.
Oncology

Florida Moves To Increase Health Insurance For Children

Capitol News Service reports that an estimated 50,000 additional uninsured children may receive medical coverage from legislation that Gov. Charlie Crist signed Tuesday. "The Kid Care program offers low cost insurance to children up to ages 19. But penalties and a lengthy application process have kept thousand of families out," Capitol News Service reports. "The legislation shortens the waiting time to enroll in the state"s Kid Care program and lessens the penalties for missing a premium payment." Children"s advocates have been pushing for the legislation for three years and call it a good start. The program enrolls 1.5 million children, but a lack of advertising money has hindered its ability to "spread the word" further (Ray, 6/2). The Miami Herald notes that the legislation will expand the role of certain advocates, known as guardians ad litem, to protect children"s legal rights. The paper also reported that "while up to 50,000 more children may get Kid Care, the bill does not expand eligibility: The children of state workers, undocumented immigrant children and pregnant women remain ineligible" (Bousquet and Reinhard, 6/2). This information was reprinted from kaiserhealthnews.org with kind permission from the Henry J. Kaiser Family Foundation. You can view the entire Kaiser Daily Health Policy Report, search the archives and sign up for email delivery at kaiserhealthnews.org. © Henry J. Kaiser Family Foundation. All rights reserved.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):